Rialto Wealth Management’s Biogen BIIB Stock Holding History

Rialto Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.3K	Buy	18 +6	+50%	+$1.11K	﹤0.01%	695
2025 Q4	$2.11K	Buy	12 +3	+33%	+$490	﹤0.01%	728
2025 Q3	$1.26K	Buy	9 +3	+50%	+$406	﹤0.01%	845
2025 Q2	$754	Sell	6 -10	-63%	-$1.25K	﹤0.01%	963
2025 Q1	$2.19K	Buy	+16	New	+$2.29K	﹤0.01%	514

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rialto Wealth Management's BIIB Position: Q1 2026 in Review

Rialto Wealth Management increased its Biogen (BIIB) stake by 50% in Q1 2026, buying an estimated $1.11K and bringing the position to 18 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Rialto Wealth Management first reported a position in BIIB in Q1 2025 and has held it in 5 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Rialto Wealth Management held 18 shares of Biogen worth $3.3K as of Q1 2026.
Rialto Wealth Management bought 6 Biogen shares in Q1 2026, an estimated $1.11K.
Biogen made up ﹤0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #695 holding.
Rialto Wealth Management first reported a position in Biogen in Q1 2025 and has held it in 5 quarters since.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.